Pediatrix Medical Group (MD) Competitors $14.42 -0.07 (-0.48%) (As of 10:46 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MD vs. AMED, AMN, CCRN, LH, DGX, DVA, CHE, CRVL, RCM, and EHCShould you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), R1 RCM (RCM), and Encompass Health (EHC). Pediatrix Medical Group vs. Amedisys AMN Healthcare Services Cross Country Healthcare Laboratory Co. of America Quest Diagnostics DaVita Chemed CorVel R1 RCM Encompass Health Pediatrix Medical Group (NYSE:MD) and Amedisys (NASDAQ:AMED) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, community ranking, profitability, analyst recommendations, media sentiment, earnings and institutional ownership. Does the MarketBeat Community favor MD or AMED? Pediatrix Medical Group received 8 more outperform votes than Amedisys when rated by MarketBeat users. Likewise, 60.31% of users gave Pediatrix Medical Group an outperform vote while only 58.72% of users gave Amedisys an outperform vote. CompanyUnderperformOutperformPediatrix Medical GroupOutperform Votes50360.31% Underperform Votes33139.69% AmedisysOutperform Votes49558.72% Underperform Votes34841.28% Do insiders and institutionals hold more shares of MD or AMED? 97.7% of Pediatrix Medical Group shares are held by institutional investors. Comparatively, 94.4% of Amedisys shares are held by institutional investors. 2.0% of Pediatrix Medical Group shares are held by insiders. Comparatively, 1.8% of Amedisys shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts recommend MD or AMED? Pediatrix Medical Group presently has a consensus target price of $16.10, indicating a potential upside of 11.81%. Amedisys has a consensus target price of $100.67, indicating a potential upside of 11.84%. Given Amedisys' higher possible upside, analysts plainly believe Amedisys is more favorable than Pediatrix Medical Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pediatrix Medical Group 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20Amedisys 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Which has better earnings & valuation, MD or AMED? Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPediatrix Medical Group$1.99B0.62-$60.41M-$3.06-4.71Amedisys$2.24B1.32-$9.75M$2.5235.72 Which has more volatility & risk, MD or AMED? Pediatrix Medical Group has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Is MD or AMED more profitable? Amedisys has a net margin of 3.57% compared to Pediatrix Medical Group's net margin of -12.65%. Pediatrix Medical Group's return on equity of 12.79% beat Amedisys' return on equity.Company Net Margins Return on Equity Return on Assets Pediatrix Medical Group-12.65% 12.79% 4.75% Amedisys 3.57%12.20%6.74% Does the media favor MD or AMED? In the previous week, Pediatrix Medical Group had 4 more articles in the media than Amedisys. MarketBeat recorded 10 mentions for Pediatrix Medical Group and 6 mentions for Amedisys. Pediatrix Medical Group's average media sentiment score of 0.58 beat Amedisys' score of 0.41 indicating that Pediatrix Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Amedisys 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryPediatrix Medical Group and Amedisys tied by winning 8 of the 16 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Pediatrix Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MD vs. The Competition Export to ExcelMetricPediatrix Medical GroupHospitals IndustryMedical SectorNYSE ExchangeMarket Cap$1.24B$5.36B$5.07B$19.90BDividend YieldN/A1.02%4.99%3.49%P/E Ratio-4.7110.4289.5636.63Price / Sales0.621.141,224.8017.98Price / Cash9.3211.5839.4521.28Price / Book1.692.536.974.58Net Income-$60.41M$178.36M$119.04M$985.06M7 Day Performance-2.31%-0.80%-1.78%0.51%1 Month Performance13.12%10.48%-3.59%1.13%1 Year Performance65.14%60.21%31.64%24.80% Pediatrix Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDPediatrix Medical Group3.5872 of 5 stars$14.42-0.5%$16.10+11.7%+61.0%$1.24B$1.99B-4.715,170Analyst ForecastNews CoverageAMEDAmedisys3.9441 of 5 stars$89.89-0.1%$100.67+12.0%-4.1%$2.94B$2.24B35.7119,000AMNAMN Healthcare Services4.7519 of 5 stars$24.76-0.2%$48.33+95.2%-63.0%$942.61M$3.79B17.973,585CCRNCross Country Healthcare4.6207 of 5 stars$10.21flat$18.50+81.2%-52.3%$336.11M$2.02B-204.1610,831Short Interest ↓LHLaboratory Co. of America4.7778 of 5 stars$237.91+0.0%$255.92+7.6%+12.7%$19.90B$12.71B46.0167,000Positive NewsDGXQuest Diagnostics4.9045 of 5 stars$162.47+0.7%$164.58+1.3%+19.7%$18.13B$9.25B21.6948,000Analyst DowngradeDVADaVita4.3779 of 5 stars$163.02+1.0%$161.80-0.7%+65.5%$13.37B$12.14B17.4170,000Positive NewsCHEChemed4.9019 of 5 stars$562.27+1.7%$641.50+14.1%-4.5%$8.46B$2.26B27.9815,087Ex-DividendPositive NewsCRVLCorVel1.4222 of 5 stars$358.67+1.0%N/A+66.0%$6.14B$795.31M75.424,870Positive NewsRCMR1 RCM3.181 of 5 stars$14.31flat$15.41+7.7%N/A$6.04B$2.25B0.0030,000News CoverageEHCEncompass Health4.8996 of 5 stars$98.64-0.3%$107.11+8.6%+52.3%$9.94B$4.80B23.8938,000Analyst Revision Related Companies and Tools Related Companies AMED Competitors AMN Competitors CCRN Competitors LH Competitors DGX Competitors DVA Competitors CHE Competitors CRVL Competitors RCM Competitors EHC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:MD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MD Stock Alerts